期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 26, 期 2, 页码 199-204出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cmi.2019.04.032
关键词
incidence; invasive pneumococcal disease; pneumococcal conjugate vaccine; pneumococcal meningitis; pneumococcal vaccination; serotype distribution; serotype replacement
资金
- Netherlands Organization for Health Research and Development (ZonMw
- NWO-Vici-Grant) [918.19.627]
- Netherlands Organization for Health Research and Development (ZonMw
- NWO-Vidi-Grant) [917.17.308]
- Academic Medical Center (AMC PhD Scholarship)
Background: Streptococcus pneumoniae is the most common pathogen causing bacterial meningitis. The routine use of multivalent conjugate pneumococcal vaccines has led to a decline of invasive pneumococcal disease caused by serotypes included in the vaccine serotypes. Recently, several reports have described a concomitant rise in the incidence of non-vaccine serotypes, suggesting serotype replacement. Objective: We aim to review the effect of pneumococcal vaccination on the incidence of pneumococcal meningitis in Europe and northern America with a particular interest in serotype replacement. Sources: Articles that include data on invasive pneumococcal disease incidence before and after the introduction of vaccination, or on invasive pneumococcal serotype, are discussed, with a focus on pneumococcal meningitis. Content: The introduction of pneumococcal conjugate vaccines has universally resulted in a decline in vaccine-serotype pneumococcal meningitis incidence throughout Europe and northern America. Serotype replacement by non-vaccine serotypes has however been reported following the introduction of the 7-, 10- and 13-valent pneumococcal conjugate vaccines, which in several regions abolished the overall effect of vaccination on pneumococcal meningitis incidence. (C) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据